Kalpit Patel
Stock Analyst at B. Riley Securities
(1.57)
# 3,497
Out of 5,148 analysts
71
Total ratings
38.78%
Success rate
-6.07%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Kalpit Patel
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| KYMR Kymera Therapeutics | Maintains: Buy | $80 → $117 | $90.10 | +29.86% | 6 | Dec 22, 2025 | |
| PDSB PDS Biotechnology | Maintains: Buy | $5 → $3 | $0.69 | +333.53% | 6 | Nov 25, 2025 | |
| ORIC ORIC Pharmaceuticals | Initiates: Peer Perform | n/a | $13.88 | - | 1 | Nov 18, 2025 | |
| CORT Corcept Therapeutics | Initiates: Peer Perform | n/a | $35.97 | - | 1 | Nov 18, 2025 | |
| JANX Janux Therapeutics | Initiates: Peer Perform | n/a | $13.42 | - | 1 | Nov 18, 2025 | |
| TNGX Tango Therapeutics | Initiates: Peer Perform | n/a | $11.53 | - | 1 | Nov 18, 2025 | |
| ACLX Arcellx | Initiates: Peer Perform | n/a | $114.05 | - | 1 | Nov 18, 2025 | |
| SMMT Summit Therapeutics | Initiates: Peer Perform | n/a | $16.19 | - | 1 | Nov 18, 2025 | |
| SRRK Scholar Rock Holding | Initiates: Outperform | $42 | $43.48 | -3.40% | 1 | Nov 18, 2025 | |
| SLNO Soleno Therapeutics | Initiates: Outperform | $75 | $39.06 | +92.01% | 1 | Nov 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $75 | $101.62 | -26.20% | 1 | Nov 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $110 | $108.30 | +1.57% | 1 | Nov 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $12 | $8.09 | +48.33% | 6 | Jul 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $17 → $14 | $5.73 | +144.33% | 7 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $37 | $23.18 | +59.62% | 1 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $20 → $24 | $34.62 | -30.68% | 6 | Mar 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5.5 → $3.5 | $1.55 | +125.81% | 4 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $9 | $5.82 | +54.64% | 4 | Jan 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $5.76 | +73.61% | 1 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $85 → $40 | $8.35 | +379.04% | 2 | Sep 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $3 | $1.66 | +80.72% | 2 | Jun 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $25 → $20 | $30.25 | -33.88% | 3 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $90 → $30 | $3.40 | +782.35% | 1 | Dec 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $34 → $36 | $22.14 | +62.60% | 2 | Jul 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $270 → $90 | $1.70 | +5,194.12% | 3 | Nov 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $21 → $18 | $2.65 | +579.25% | 2 | Sep 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $5 | $1.37 | +264.96% | 2 | Jul 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $240 → $100 | $10.90 | +817.43% | 1 | Jan 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $75 | $30.65 | +144.70% | 2 | Sep 3, 2021 |
Kymera Therapeutics
Dec 22, 2025
Maintains: Buy
Price Target: $80 → $117
Current: $90.10
Upside: +29.86%
PDS Biotechnology
Nov 25, 2025
Maintains: Buy
Price Target: $5 → $3
Current: $0.69
Upside: +333.53%
ORIC Pharmaceuticals
Nov 18, 2025
Initiates: Peer Perform
Price Target: n/a
Current: $13.88
Upside: -
Corcept Therapeutics
Nov 18, 2025
Initiates: Peer Perform
Price Target: n/a
Current: $35.97
Upside: -
Janux Therapeutics
Nov 18, 2025
Initiates: Peer Perform
Price Target: n/a
Current: $13.42
Upside: -
Tango Therapeutics
Nov 18, 2025
Initiates: Peer Perform
Price Target: n/a
Current: $11.53
Upside: -
Arcellx
Nov 18, 2025
Initiates: Peer Perform
Price Target: n/a
Current: $114.05
Upside: -
Summit Therapeutics
Nov 18, 2025
Initiates: Peer Perform
Price Target: n/a
Current: $16.19
Upside: -
Scholar Rock Holding
Nov 18, 2025
Initiates: Outperform
Price Target: $42
Current: $43.48
Upside: -3.40%
Soleno Therapeutics
Nov 18, 2025
Initiates: Outperform
Price Target: $75
Current: $39.06
Upside: +92.01%
Nov 18, 2025
Initiates: Outperform
Price Target: $75
Current: $101.62
Upside: -26.20%
Nov 18, 2025
Initiates: Outperform
Price Target: $110
Current: $108.30
Upside: +1.57%
Jul 30, 2025
Maintains: Buy
Price Target: $9 → $12
Current: $8.09
Upside: +48.33%
May 2, 2025
Maintains: Neutral
Price Target: $17 → $14
Current: $5.73
Upside: +144.33%
Mar 20, 2025
Initiates: Buy
Price Target: $37
Current: $23.18
Upside: +59.62%
Mar 5, 2025
Maintains: Neutral
Price Target: $20 → $24
Current: $34.62
Upside: -30.68%
Feb 18, 2025
Maintains: Buy
Price Target: $5.5 → $3.5
Current: $1.55
Upside: +125.81%
Jan 31, 2025
Maintains: Buy
Price Target: $7 → $9
Current: $5.82
Upside: +54.64%
Jan 30, 2025
Initiates: Buy
Price Target: $10
Current: $5.76
Upside: +73.61%
Sep 20, 2024
Maintains: Buy
Price Target: $85 → $40
Current: $8.35
Upside: +379.04%
Jun 18, 2024
Maintains: Buy
Price Target: $9 → $3
Current: $1.66
Upside: +80.72%
May 9, 2024
Downgrades: Neutral
Price Target: $25 → $20
Current: $30.25
Upside: -33.88%
Dec 12, 2023
Downgrades: Neutral
Price Target: $90 → $30
Current: $3.40
Upside: +782.35%
Jul 25, 2023
Maintains: Buy
Price Target: $34 → $36
Current: $22.14
Upside: +62.60%
Nov 11, 2022
Downgrades: Neutral
Price Target: $270 → $90
Current: $1.70
Upside: +5,194.12%
Sep 22, 2022
Maintains: Buy
Price Target: $21 → $18
Current: $2.65
Upside: +579.25%
Jul 19, 2022
Maintains: Buy
Price Target: $6 → $5
Current: $1.37
Upside: +264.96%
Jan 24, 2022
Maintains: Buy
Price Target: $240 → $100
Current: $10.90
Upside: +817.43%
Sep 3, 2021
Downgrades: Neutral
Price Target: $75
Current: $30.65
Upside: +144.70%